电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

PD-1 抗体

This anti-PD-1 antibody is a 大鼠 单克隆 antibody detecting PD-1 in BCA. Suitable for 小鼠.
产品编号 ABIN2664493
发货至: 中国

Quick Overview for PD-1 抗体 (ABIN2664493)

抗原

See all PD-1 (PDCD1) 抗体
PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

适用

  • 207
  • 92
  • 27
  • 5
  • 4
  • 3
小鼠

宿主

  • 108
  • 107
  • 41
  • 13
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
大鼠

克隆类型

  • 199
  • 76
  • 5
单克隆

标记

  • 148
  • 19
  • 13
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PD-1 antibody is un-conjugated

应用范围

  • 148
  • 109
  • 95
  • 59
  • 46
  • 32
  • 27
  • 27
  • 20
  • 18
  • 13
  • 13
  • 13
  • 10
  • 9
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Biochemical Assay (BCA)

克隆位点

RMP1-30
  • 纯化方法

    The antibody was purified by affinity chromatography.

    亚型

    IgG2b kappa
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 浓度

    1.0 mg/mL

    缓冲液

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and EDTA.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C

    储存方法

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • 抗原

    PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

    别名

    CD279

    背景

    CD279 is a 50-55 kD immunoglobulin superfamily member also known as programmed death-1 (PD-1). PD-1 is expressed on a subset of CD4-CD8- thymocytes and on activated T and B cells. PD-1 is thought to be involved in lymphocyte clonal selection and peripheral tolerance. The PD-1 ligands, PD-L1 (also known as B7-H1) and PD-L2 (B7-DC), are members of the B7 immunoglobulin superfamily.

    途径

    Cancer Immune Checkpoints
You are here:
Chat with us!